Chimerix, Inc.
CMRX
CMRX was delisted on the 17th of April, 2025.
73 hedge funds and large institutions have $32.5M invested in Chimerix, Inc. in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 21 reducing their positions, and 13 closing their positions.
6% less funds holding
Funds holding: 78 → 73 (-5)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
21% less capital invested
Capital invested by funds: $41.1M → $32.5M (-$8.63M)
33% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 21
65% less call options, than puts
Call options by funds: $63K | Put options by funds: $178K
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$440K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$432K |
| 3 |
Renaissance Technologies
New York
|
-$351K |
| 4 |
Barclays
London,
United Kingdom
|
-$308K |
| 5 |
SPS
Susquehanna Portfolio Strategies
Bala Cynwyd,
Pennsylvania
|
-$145K |
CMRX Hedge Fund Activity: Q2 2024 in Review
73 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Chimerix, Inc. (CMRX) for Q2 2024, worth a combined $32.5M — down 21% from $41.1M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CMRX and 11 opened new positions — a net loss of 2 holders — while 21 trimmed existing stakes and 14 added.
The largest buyer was Adage Capital Partners, adding an estimated $190K. The largest seller was Goldman Sachs, cutting an estimated $440K.
- 73 institutional investors held Chimerix, Inc. (CMRX) as of Q2 2024, down from 78 in Q1 2024.
- Funds reported $32.5M of Chimerix, Inc. stock for Q2 2024, down 21% quarter-over-quarter.
- 11 funds opened new Chimerix, Inc. positions in Q2 2024 and 13 closed out, a net change of -2 holders.
- The largest Chimerix, Inc. buyer in Q2 2024 was Adage Capital Partners, an estimated $190K added.
- The largest Chimerix, Inc. seller in Q2 2024 was Goldman Sachs, an estimated $440K sold.
Based on aggregated 13F filings for Q2 2024.